Published: Tue, October 17, 2017
Business | By Kate Woods

Impax Laboratories, Inc. (NASDAQ:IPXL) Sees Unusual Trading Volume in Its Shares

Impax Laboratories Inc. had 40 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has "Hold" rating given on Friday, October 6 by RBC Capital Markets. Piper Jaffray has "Hold" rating and $17.0 target. The rating was upgraded by PiperJaffray to "Neutral" on Monday, November 28. The firm earned "Buy" rating on Friday, July 14 by Goldman Sachs. Piper Jaffray maintained the stock with "Hold" rating in Wednesday, August 9 report. Gabelli initiated the shares of BKS in report on Monday, October 12 with "Buy" rating. The firm has "Neutral" rating by Seaport Global given on Tuesday, May 24. The most recent short interest data show 9.22% of the company's stock are short sold. IPXL's SI was 8.08 million shares in October as released by FINRA.

North Tide Capital Llc holds 3.58% of its portfolio in Impax Laboratories Inc for 1.00 million shares. The SI to Impax Laboratories Incorporated's float is 12.2%. The stock increased 0.69% or $0.05 during the last trading session, reaching $7.3. About 37,522 shares traded. (NasdaqGS:IPXL) is 3. A score of nine indicates a high value stock, while a score of one indicates a low value stock. It has underperformed by 65.71% the S&P500.

Analysts await Impax Laboratories Inc (NASDAQ:IPXL) to report earnings on November, 8. (NASDAQ:IPXL)'s Buy count is 0 and Strong Buy is 2 while the number of analysts recommending Sell and Strong Sell are 0 and 7, respectively. Therefore 25% are positive. After having $0.18 EPS previously, Impax Laboratories Inc's analysts see 5.56% EPS growth. The stock of Impax Laboratories Inc (NASDAQ:IPXL) earned "Market Perform" rating by Northland Capital on Tuesday, April 19. (NYSE:BKS) has "Buy" rating given on Monday, July 27 by Craig Hallum. California-based Gemmer Asset Mgmt Lc has invested 0% in Impax Laboratories Inc (NASDAQ:IPXL). The count of Hold ratings in that period was 0. The firm has "Sector Perform" rating given on Thursday, November 10 by RBC Capital Markets. BMO Capital Markets maintained Impax Laboratories Inc (NASDAQ:IPXL) rating on Friday, June 23.

More news: Madame Tussauds-owner Merlin blames attacks for dip in summer trade

Trading volume for Impax Laboratories, Inc. was 4,910 on Tuesday. The company was initiated on Wednesday, October 7 by Cantor Fitzgerald.

The analysts offering 12 month price targets for Impax Laboratories, Inc. have a median target of $19, with a high estimate of $27 and a low estimate of $12. Harvey Partners Llc who had been investing in Orion Engineered Carbons S A for a number of months, seems to be bullish on the $1.41 billion market cap company. The Company is involved in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. Checking in on some other ratios, the company has a Price to Cash Flow ratio of 14.797532, and a current Price to Earnings ratio of -2.668765.

If the two United States drugmakers were to join forces, they would create the USA's fifth-largest generic-drug company by revenue, the article adds, and one expected to be worth $6.4 billion, or around $9 billion with debt.

More news: Motorola to launch Moto X4 on November 13 in India

Since January 1, 0001, it had 0 insider purchases, and 3 insider sales for $43,046 activity. The FCF Score of Impax Laboratories, Inc.

Impax 2017 guidance: non-GAAP EPS: $0.55 - 0.70. Its up 0.54, from 1.68 in 2017Q1. It is negative, as 28 investors sold IPXL shares while 53 reduced holdings. 16 funds opened positions while 24 raised stakes. NESTOR MICHAEL sold $14,119 worth of Impax Laboratories Inc (NASDAQ:IPXL) on Wednesday, May 17. Bank Of Montreal Can invested 0% in Impax Laboratories Inc (NASDAQ:IPXL). Balyasny Asset Management Limited Com invested in 0.07% or 1.05 million shares. Teachers Retirement Of The State Of Kentucky has 25,200 shares. Brandywine Inv Mngmt Limited Liability Company invested in 0.01% or 105,336 shares. Swiss Fincl Bank invested 0% of its portfolio in Impax Laboratories Inc (NASDAQ:IPXL). Amer International Gp owns 55,009 shares for 0% of their portfolio. Legal And General Grp Pcl holds 0% or 142,452 shares. Dupont Capital reported 0.02% of its portfolio in Impax Laboratories Inc (NASDAQ:IPXL). The New York-based Metropolitan Life Insurance Communications Ny has invested 0.01% in Impax Laboratories Inc (NASDAQ:IPXL). Jpmorgan Chase Com reported 394,737 shares. Adirondack Trust reported 31,980 shares stake.

Lindsay Corporation, along with its subsidiaries, provides a range of water management and road infrastructure services and products. The company is taking steps to reduce costs and improve efficiencies, which may save an estimated $130 million by the end of 2019. The Irrigation Segment includes the manufacture and marketing of center pivot, lateral move, and hose reel irrigation systems, which are used primarily in the agricultural industry.

More news: This Weeks Target Prices For Urban Outfitters, Inc. (NASDAQ:URBN)

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Like this: